Montanide ISA-720 Adjuvant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Montanide ISA-720 Adjuvant, covering 2026-02-09 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers [Phase 1]